Chapel Hill startup with ties to UNC lands rights to drug offering hope to cystic fibrosis patients

Posted Oct 27, 2019
Path BioAnalytics (PBA), a precision medicine startup with ties to UNC, has scored the rights to a new drug therapy offering hope to cystic fibrosis (CF) patients with rare mutations. PBA is a graduate of Launch Chapel Hill, an accelerator program based in Chapel Hill, as well as the Kenan Flagler Business School program Startup UNC. (WRAL Tech Wire)

Related: Campus Connections

Video: IC Podcast - Touch 'Em All with Larry Keith
"Touch 'Em All: My Life and Career at Sports Illustrated" is Larry Keith's memoir about an accomplished writer and editor who began his career at...
Wed Nov 5, 2025

A guide to Chapel Hill's live music scene
Chapel Hill’s live music scene is bustling and evergreen. Music venues in Chapel Hill and Carrboro have shows almost every single night. Student musicians make...
Wed Nov 5, 2025

Ghosts of UNC's past and present
Every October, the whispers of UNC’s past seem to echo a little louder. For decades, students and staff have swapped legends of spirits that are...
Mon Nov 3, 2025

Residents flock to spooktacular Halloween celebration on Franklin Street
Hundreds of people flocked to Franklin Street on Friday to celebrate Halloween in Chapel Hill, North Carolina. The college town has been a popular spot...
Sat Nov 1, 2025